Dynatrace Holdings DT 深 沪
等待开盘 07-06 09:30:00 美东时间
44.77
-0.610
-1.34%
华盛通- 最 高45.99
- 今 开45.26
- 成交量 518.26万股
- 最 低 44.68
- 昨 收 45.38
- 总市值 130.49亿
- 52周最高 55.49
- 市盈率 静 83.59
- 换手率 1.78%
- 52周最低 31.635
- 委 比 11.11%
- 总股本 2.91亿
- 历史最高 80.128
- 量 比 0.64
- 振 幅 2.89%
- 历史最低 17.05
- 每 手 1
- 风险率 5.84%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Needham Reiterates Hold on Dynatraceto Hold
Needham analyst Mike Cikos reiterates Dynatrace (NYSE:DT) from Hold to Hold.
06-25 19:38
美股大行评级 | 潜在涨幅117.92%！摩根大通上调Camp4 Therapeutics目标价至9美元，维持"超配"评级
今日重点评级关注：摩根大通：上调Camp4 Therapeutics评级至"超配"，目标价从5美元升至9美元；Canaccord Genuity：维持Rhythm制药"买入"评级，目标价从143美元升至151美元
06-17 11:32
UBS Upgrades Dynatrace to Buy, Raises Price Target to $60
UBS analyst Radi Sultan upgrades Dynatrace (NYSE:DT) from Neutral to Buy and raises the price target from $36 to $60.
06-16 20:31
Shares of software companies are trading lower amid overall market weakness as investors rotate out of growth stocks.
Shares of software companies are trading lower amid overall market weakness as ...
06-10 01:41
Shares of companies within the broader technology sector are trading higher amid overall market strength. The sector may be rallying in response to AMD CEO Lisa Su's warm comments about an expansion in the CPU market and Lenovo Group's strong Q4 financial results.
Shares of companies within the broader technology sector are trading higher ami...
05-23 03:43
William Blair Assumes Dynatrace at Outperform
William Blair analyst Jonathan Ho assumes Dynatrace (NYSE:DT) with a Outperform rating.
05-21 22:00
财报速睇 | Dynatrace Holdings 2026财年年度营收20.18亿美元，同比增长18.8%；归母净利润1.63亿美元，同比下滑66.3%
华盛资讯5月21日讯，Dynatrace Holdings公布2026财年年度业绩，公司年度营收20.18亿美元，同比增长18.8%，归母净利润1.63亿美元，同比下滑66.3%。
05-21 12:17
美股大行评级 | 阿里、京东、英伟达、思科等获多家大行上调目标价；Doximity、Dynatrace、Enovix、Wix.com等遭多家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Autolus Therapeutics"买入"评级，目标价从9美元升至10美元；Maxim Group：维持Rezolute"买入"评级，目标价从4美元升至10美元
05-15 10:49
美股大行评级 | 潜在涨幅257.14%！瑞杰金融上调InflaRx目标价至9美元，评级升至"强烈买入"
今日重点评级关注：瑞杰金融：上调InflaRx评级至"强烈买入"，目标价从7美元升至9美元；巴克莱：维持Orchestra BioMed Hldgs"超配"评级，目标价从12美元升至13美元
05-14 14:32
BTIG Maintains Buy on Dynatrace, Lowers Price Target to $47
BTIG analyst Gray Powell maintains Dynatrace (NYSE:DT) with a Buy and lowers the price target from $53 to $47.
05-14 01:49
